1-1 of 1
Karan Kanhai
Close
Sort by
Journal Articles

Siltuximab is associated with improved progression-free survival in idiopathic multicentric Castleman disease

Frits van Rhee, Adam Rosenthal, Karan Kanhai, Rabecka Martin, Katherine Nishimura, Antje Hoering, David C. Fajgenbaum
Journal: Blood Advances
Blood Adv (2022) 6 (16): 4773–4781.
https://doi.org/10.1182/bloodadvances.2022007112
Published: 2022
Includes: Supplemental data